Aligos Therapeutics (ALGS) FCF Margin Growth (3y) (2024 - 2026)
Aligos Therapeutics (ALGS) FCF Margin Growth (3y) (2024 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.71 Bn | 130.86 Bn | 2.84 Bn | -1,272.00 |
| 2 | Regeneron Pharmaceuticals | 85.60 Bn | 77.60 Bn | 3.93 Bn | -2,228.00 |
| 3 | Argenx Se | 64.82 Bn | 59.63 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.92 Bn | 52.79 Bn | 52.00 Mn | -5,426.00 |
| 5 | BeOne Medicines | 41.88 Bn | 36.78 Bn | 1.53 Bn | 9,545.00 |
| 6 | Alnylam Pharmaceuticals | 31.46 Bn | 28.15 Bn | 992.69 Mn | 4,612.00 |
| 7 | BioNTech SE | 27.96 Bn | 9.57 Bn | 668.28 Mn | 1,850.00 |
| 8 | Insmed | 27.35 Bn | 26.19 Bn | 358.27 Mn | 14,060.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -3,088.00 |
| 10 | Aligos Therapeutics | 68.32 Mn | 37.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.52 Mn |
| Dec 31, 2025 | -1.27 Mn |
| Mar 31, 2025 | -590,833.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 4,872.00 |
| Jun 30, 2024 | -33,755.00 |
| Mar 31, 2024 | 3,050.00 |